I said I was willing to get a money manager and set up a retirement account in both of our names. I’ve always worked, even while raising our daughter.
Shares of Moderna Inc. undefined gained 5.2% in trading on Wednesday after a company executive told a government advisory committee that its experimental COVID-19 vaccine had triggered antibodies in elderly patients. Dr. Jacqueline Miller, the company's SVP of infectious disease development, told the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices that neutralizing antibody titers were reported in all age groups that are currently being studied: 18 to 55 years old, 56 to 70 years old, and 71 years and older. This is the first time that Moderna has released data about how its vaccine candidate has performed in an older patient population; the data it shared about how the investigational vaccine fared in the Phase 1 trial was for people between the ages of 18 and 55 years old. Moderna's stock is up 251.2% year-to-date, compared with the S&P 500 undefined, which is up 6.6%.
The concerns expressed are in relation to a commonly used cell line derived from foetal kidney cells
Get the latest news from MarketWatch on COVID-19.
With the virus still on the loose, the economy is likely to stall again, says Stephen Roach
Facebook Inc. shares were up 5% to $295.95 in late-morning trading Wednesday as the social-networking giant neared $300 a share for the first time...
The Energy Information Administration reported Wednesday that U.S. crude inventories fell by 4.7 million barrels for the week ended Aug. 21, markin...
McDonald's Corp. will add a little heat to its menu this fall with new Spicy Chicken McNuggets and an accompanying Mighty Hot Sauce. The items wil...
Shares of Salesforce.com Inc. are up 28% in Wednesday morning trading after the software company reported better-than-expected fiscal second-quart...
Shares of PTC Therapeutics Inc. were down 0.9% in trading on Wednesday after the company said it received its first milestone payment of $20 milli...
The thought must’ve crossed many investors’ minds during the pandemic. Why not just get out of the market entirely?
Watch out, FIRE fans: New reports say retiring early can give you Alzheimer’s
‘The sad fact is that herd immunity just isn’t a solution to our pandemic woes.’
30 yr fixed Jumbo | 3.11% |
30 yr fixed | 3.07% |
15 yr fixed | 2.62% |
10 yr fixed | 2.63% |
30 yr fixed refi | 3.25% |
15 yr fixed refi | 2.70% |
5/1 ARM | 3.33% |
5/1 ARM refi | 3.48% |
$30K HELOC | 1.99% |
$50K HELOC | 5.00% |
$75K HELOC | 1.99% |
$100K HELOC | 5.00% |
$30K Home Equity Loan | 5.24% |
$50K Home Equity Loan | 3.74% |
$75K Home Equity Loan | 3.74% |
$100K Home Equity Loan | 4.12% |
5 yr CD | 0.66% |
2 yr CD | 0.49% |
1 yr CD | 0.45% |
MMA $10K+ | 0.17% |
MMA $50K+ | 0.24% |
MMA Savings | 0.24% |
MMA Savings Jumbo | 0.26% |
60 Mo Used Car | 4.35% |
48 Mo Used Car | 4.67% |
36 Mo Used Car | 4.74% |
72 Mo New Car | 4.21% |
60 Mo New Car | 4.44% |
48 Mo New Car | 4.25% |
60 Mo Auto Refi | 4.50% |
36 Mo Auto Refi | 4.25% |
Quentin Fottrell answers your questions about inheritance, tipping, weddings, re-gifting, or any tricky money issues relating to family and friends. Have a question? Send it to the Moneyist.
The ‘adverse market’ fee is being implemented to cover $6 billion in projected losses caused by COVID-19.
Sales of new single-family houses rose 14% between June and July to a seasonally-adjusted annual rate of 901,000, the U.S. Census Bureau reported T...
Connecting affluent buyers with luxury listings.